AM580-CD336-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁
AM580-CD336-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁
AM580-CD336-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁
AM580-CD336-DataSheet-生命科學(xué)試劑-MedChemExpress_第4頁
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEAM580Cat. No.: HY-10475CAS No.: 102121-60-8Synonyms: CD336; NSC608001; Ro 40-6055分式: CHNO分量: 351.44作靶點(diǎn): RAR/RXR; Autophagy作通路: Metabolic Enzyme/Protease; Autophagy儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1

2、month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 45 mg/mL (128.04 mM)H2O : 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (7.11 mM); Clear solution2. 請依序添加每種溶劑: 10% DMSO 90% corn oil1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemESolubility: 2.5 mg/mL (7.11 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 AM580是選擇性的 RAR 激動(dòng)劑

3、,IC50 和 EC50 分別為8 nM,0.36 nM。體外研究 In the presence of G-CSF, AM580 (at 10-8 M) produces a remarkable induction in LAP mRNA of NB4 cells.At a concentration of 10-5 M, AM580 and ATRA, in combination with G-CSF, induce almost the same level ofLAP transcript. AM580 (at 10-8 M) leads to an approximately s

4、ixfold increase in the steady-state levels of thetranscript coding for the G-CSF receptor in NB4 cells 1. AM580 (50 nM) increases caspase-3 expression inall of the colonies, and in 30% of the colonies induce acinar-like cavitation 2. Knockdown of RAR1 inprimary Myc cells using shRAR1 followed by Am5

5、80 treatment results in an even higher level of CRBP1expression, showing that in these cells RAR has a repressive effect on the RAR target gene CRBP1.Am580 (200 nM) enhances the anti-proliferative effect exhibited by RAR knockdown in the MCF-10A andMCF-7 cell lines but not in the MDA-MB-231 cells 3.

6、體內(nèi)研究 Am580 (0.3 mg/kg/day) treatment has a more profound effect on tumor-free survival of MMTV-wnt1 mice, theeffect being noticeable even in early appearing tumors, and no overt toxicity is found in liver, lungs, kidney,and spleen. Am580 treatment reduces substantially and equally the level of hyper

7、plasia in both transgenicglands 2. Treatment of MMTV-Myc mice with the RAR-selective agonist Am580 leads to significantinhibition of mammary tumor growth, lung metastasis and extends tumor latency in 63% of mice 3.PROTOCOLKinase Assay 1 Approximately 1106 NB4, HL-60, and APL fresh leukemic cells or

8、CML neutrophils are harvested, pellettedby centrifugation at 400 g for 10 minutes, washed once with 0.9% NaCl, and centrifuged again. The washedcell pellet is resuspended in homogenization buffer (1 mM MgCl2, 1 mM CaCl2, 20 mM ZnCl2, 0.1 mM NaCl,0.1% vol/vol Triton X-100, 50 mM Tris/HCl, pH 7.4) and

9、 disrupted by vigorous pipetting. The homogenate isused for the LAP assay, which is performed with p-nitrophenol phosphate as substrate according to theinstructions of the manufacturer. LAP activity is normalized for the content of protein in the sample. Proteinsare measured according to the Bradfor

10、d method using BSA fraction V as a standard. One unit of LAP activityis defined as the amount of enzyme capable of transforming 1 nmol of substrate in 1 minute at 25C. Enzymeassays are performed in conditions of linearity relative to the substrate and to the concentration of proteins.MCE has not ind

11、ependently confirmed the accuracy of these methods. They are for reference only.Cell Assay 1 MCF-10A (2104) control cells or overexpressing RAR are seeded in triplicates in 6-well culture dishes.After 24 hrs, cells are washed with PBS, incubated in 2 mL of DMEM-F12 culture medium, detached andcounte

12、d every 24 hrs. Statistical significance is determined by t-test. pRB and p27 expression is tested byimmunofluorescence analysis of control MCF-10A monolayers and monolayers stably transfected with pSG5-RAR expression vector, using the same antibodies described for the IHC analysis.MCE has not indep

13、endently confirmed the accuracy of these methods. They are for reference only.2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEAnimal Four months old uniparous (1 pregnancy/lactation cycle) MMTV-neu and 6 weeks old nulliparous MMTV-Administration 1 wnt1 female mice (50 mice/group) are treated with t

14、he RAR agonist AM580 (0.3 mg/kg body weight permouse per day) in the diet (Purina 5053) by adding 1.5 mg AM580 per kg of Purina 5053 diet. Mice thatdevelop tumors within the first month of treatment are removed from the study. Mice are palpated twice aweek and tumor appearance is recorded. Once palp

15、able, the size of the tumors is measured weekly. Tumor-free survival is calculated from Kaplan-Meier curves and statistical significance is determined by the Log-ranktest for the survival studies and t-test for the tumor growth studies. Metastasis is evaluated by removing thelungs of all the anesthe

16、tized mice, selecting randomLy 20 mice per group and inspecting the lung surface forlesions using a stereoscope.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Giann M, et al. AM580, a stable benzoic derivative of retinoic acid, has powerfu

17、l and selective cyto-differentiating effects on acutepromyelocytic leukemia cells. Blood. 1996 Feb 15;87(4):1520-31.2. Lu Y, et al. Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.Oncogene. 2010 Jun 24;29(25):3665-76.3. Bosch A, et al. Reversal by RAR agonist Am580 of c-Myc-induced imbalance in RAR/RAR expression during MMTV-

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

最新文檔

評論

0/150

提交評論